Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study

This cohort highlights prognostic factors for patients with DHG, H3 G34, describes relapse patterns, and therapy approaches. Clinical trials and prospective registries are needed to improve outcomes.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2026-03-09
DOI
https://doi.org/10.1158/1078-0432.ccr-25-3764
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study

D. Sturm, Yuhei Sangatsuda, Mary-Pat Schlosser, Mariah L. Wright et al.
Clinical Cancer Research
Glioma Diagnosis and Treatment
article

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-mutant: An International Multi-Institutional Study

D. Sturm, Yuhei Sangatsuda, Mary-Pat Schlosser, Mariah L. Wright, Uğur Sener, Egiroh Omene, Brandon S. Imber, N. Andre, Louise Ludlow, Jordan R. Hansford, Craig Erker, Charlotte R. Feddersen, Cameron Crowell, K. Matheson, Rebecca J. Ronsley, Nikhil P. Mankuzhy, Sarah Lapointe, Darren Klawinski, Magimairajan Vanan, Adam L. Green, Mary MacNeil, Ralph Salloum, K. L. Ligon, Sonal Patel, Nikoleta Juretic, G. Chinnaswamy, Abhishek Chatterjee, Dong-Anh Khuong-Quang, Émeline Tabouret, Sheila McThenia, Andrew E. Williams, Maya Prasad, Romain Cayrol, Robert Galvin, Olivia Vizzini, Pratiti Bandopadhayay, Emily Lin, Sébastien Perreault, Christina Coleman, Aimee Popovacki, Sara Khan, Aimee Chan, Jacquelyn Jones, Miriam Pavon-Mengual, David T.W. Jones, Samuele Renzi, Julie Bennett, Tejpal Gupta, David Eisenstat, Cynthia Hawkins, Sridhar Epari, Ofelia Cruz, Michal Zápotocký, Kimberley L. Alexander, Nada Jabado, Laveniya Satgunaseelan, Koji Yoshimoto, Mary Jane Lim-Fat, Sylvia Cheng, Kristin Yao, Daddy Mata-Mbemba, Matthias A. Karajannis, Valérie Larouche
article en

Abstract

This cohort highlights prognostic factors for patients with DHG, H3 G34, describes relapse patterns, and therapy approaches. Clinical trials and prospective registries are needed to improve outcomes.

Clinical Cancer Research
University of Minnesota (US), Hospital Sant Joan de Déu Barcelona (ES), Nationwide Children's Hospital (US), Royal Children's Hospital (AU), Sunnybrook Health Science Centre (CA), Mayo Clinic (US), Memorial Sloan Kettering Cancer Center (US), NorthShore University HealthSystem (US), Kyushu University (JP), University of Alberta (CA), The University of Melbourne (AU), University of Toronto (CA), Royal Prince Alfred Hospital (AU), Montreal Children's Hospital (CA), Tata Memorial Hospital (IN), Queen Elizabeth II Health Sciences Centre (CA), Izaak Walton Killam Health Centre (CA), University of Minnesota System (US), Hospital for Sick Children (CA), McGill University Health Centre (CA), Centre Hospitalier Universitaire Sainte-Justine (CA), Nova Scotia Health Authority (CA), Assistance Publique Hôpitaux de Marseille (FR), Chris O’Brien Lifehouse (AU), University Hospital in Motol (CZ), Nemours Children's Health System (US), Seattle Children's Hospital (US), Hopp Children's Cancer Center Heidelberg (DE), Dana-Farber Cancer Institute (US), Mayo Clinic in Arizona (US), Mayo Clinic Hospital (US), University of Colorado Cancer Center (US), South Australian Health and Medical Research Institute (AU), Centre hospitalier de l'Université Laval (CA), Centre Hospitalier de l’Université de Montréal (CA), Mayo Clinic in Florida (US), Children's Healthcare of Atlanta (US), Murdoch Children's Research Institute (AU), BC Children's Hospital (CA), Hôpital de la Timone (FR), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), Université Laval (CA), University of Manitoba (CA), McGill University (CA), University of Virginia (US), University of Colorado Anschutz Medical Campus (US), Green Cross International (US), University of Colorado Denver (US)
Openalex Percentile: Top 29%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.